A groundbreaking study published in The Lancet has brought renewed attention to cervical cancer inequalities across Canada, highlighting how disparities in incidence and mortality persist despite advances in prevention. Led by Professor Marc Brisson from Université Laval, the research uses advanced mathematical modeling to project future trends, underscoring the critical role Canadian universities play in addressing this public health challenge. While high-income countries like Canada are on track to eliminate cervical cancer as a public health problem by 2048 under current vaccination and screening efforts, provincial variations and socioeconomic factors reveal ongoing gaps that demand targeted interventions from academic institutions and policymakers alike.

Cervical cancer, caused primarily by persistent infection with high-risk types of human papillomavirus (HPV), remains preventable through vaccination, regular screening, and early treatment. In Canada, organized screening programs exist in nine provinces, yet adherence rates and outcomes differ significantly by region, income level, and ethnicity. This study not only maps global projections but also spotlights the need for Canada to strengthen its strategies to close these domestic divides.

The Université Laval-Led Lancet Study: Key Insights

Professor Marc Brisson, from the Centre de recherche du CHU de Québec-Université Laval and Département de médecine sociale et préventive at Université Laval, spearheaded this global modeling effort using the HPV-ADVISE model. Published on May 2, 2026, the study analyzes 42 high-income countries (HICs), including Canada, and 67 low- and middle-income countries (LMICs). Under status quo policies—current HPV vaccination coverage for girls and screening practices—HICs are projected to achieve elimination (age-standardized incidence below 4 per 100,000 women-years) by 2048. However, LMICs would see only a 23% reduction in incidence by 2105, widening the global ratio from 3 in 2022 to 12.

For Canada specifically, the model affirms progress toward elimination but warns of internal inequalities. Brisson noted in related coverage, "Compared to Canada, we're even talking about 40 times higher" rates in some LMICs, emphasizing the moral imperative for enhanced global efforts. Université Laval's expertise in HPV dynamics, built on years of modeling, positions it as a leader in predictive epidemiology, informing national strategies like those from the Canadian Cancer Society.

Cervical Cancer Burden and Provincial Disparities in Canada

Canada's cervical cancer incidence has plateaued after decades of decline, with an estimated 1,600 new cases and 400 deaths in 2024, projected to rise slightly. Age-standardized rates vary starkly by province: in 2022, Prince Edward Island reported 4.4 cases per 100,000 women, while Saskatchewan had 11.8—the highest. Other figures include Manitoba at 7.1 and New Brunswick at 9.5 per 100,000.

These disparities correlate with screening adherence, which exceeds the 80% national target in most areas but lags among immigrants, low-income groups, and certain ethnicities. For instance, South Asian and Middle Eastern women in Ontario show lower participation. Université Laval's projections stress that without equity-focused enhancements, these gaps could persist even as overall rates fall.

Socioeconomic and Ethnic Inequalities: Evidence from Canadian Studies

Research from Dalhousie University and others reveals widening socioeconomic gradients in mortality from 1992-2019, with higher rates in lower income quintiles. A 2024 Public Health study confirmed increasing education-based inequalities. Ethnic disparities are evident too: immigrant women screen 27% less in Ontario.

McGill University's Division of Cancer Epidemiology has long tracked HPV and cervical cancer natural history, contributing data to global models like Brisson's. Their work shows how factors like access to primary care exacerbate risks in underserved communities.

HPV Vaccination and Screening: Provincial Programs and University Innovations

Nine provinces have organized screening, shifting to HPV primary testing in places like BC, Ontario, and Quebec. Vaccination coverage: Ontario 68%, Quebec 84.5% for females. Yet, gaps remain.

• BC Cancer Agency/UBC: Gina Ogilvie leads HPV Focal, advancing self-sampling for equity.
• University of Saskatchewan: National project for elimination.
• UCalgary: Dr. Richa Pandey develops simplified screening tools.

Universities drive innovation: The Lancet study credits such efforts for HIC progress. Partnerships with the Canadian Cancer Society amplify reach.

Canadian Universities' Broader Contributions to Cervical Cancer Research

Beyond Laval, UBC's Ogilvie secured CIHR funding for HPV control. McGill models prevention impacts. UofT's Aisha Lofters addresses immigrant screening inequities via Women's College Hospital research.

These institutions train future leaders, with programs in epidemiology and public health tackling disparities head-on.

Challenges: Access, Awareness, and Equity

Barriers include rural access, cultural stigma, and pandemic disruptions. Provinces like Saskatchewan face higher rates due to lower screening. Universities advocate for self-collection kits and mobile clinics.

Solutions and Policy Recommendations from Academia

• Boost HPV vaccination to 90% with boys included.
• Universal screening at 70% via self-sampling.
• Targeted outreach for high-risk groups.
• Fund university-led trials for equity.

The study urges WHO targets; Canadian unis like Laval propose modeling for tailored interventions.

Future Outlook: Canada's Path to Elimination

With university research, Canada can eliminate by 2048. Projections show potential for equity if enhanced. Canadian Cancer Society data supports optimism.

Stakeholder Perspectives: Voices from Canadian Academia

Brisson: Urgent enhanced strategies needed. Ogilvie: HPV testing gamechanger. Lofters: Address immigrant barriers.

Actionable Insights for Universities and Communities

Unis can expand outreach, research, training. Explore research jobs in oncology at Canadian institutions.

Photo by charlesdeluvio on Unsplash